


文档简介
1、Product Data SheetGenistinCat. No.: HY-N0595CAS No.: 529-59-9分式: CHO分量: 432.38作靶点: Autophagy作通路: Autophagy储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 100 mg/mL (231.28 mM)* means soluble, but saturation unknown.SolventMass1 mg 5 mg 10 mgConcentration制备储备液1
2、mM 2.3128 mL 11.5639 mL 23.1278 mL5 mM 0.4626 mL 2.3128 mL 4.6256 mL10 mM 0.2313 mL 1.1564 mL 2.3128 mL请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;旦配成溶液,请分装保存,避免反复冻融造成的产品失效。储备液的保存式和期限:-80C, 6 months; -20C, 1 month。-80C 储存时,请在 6 个内使,-20C 储存时,请在 1 个内使。体内实验请根据您的实验动物和给药式选择适当的溶解案。以下溶解案都请先按照 In Vitro 式配制澄清的储备液,再依次添加助溶剂:为
3、保证实验结果的可靠性,澄 的储备液可以根据储存条件,适当保存;体内实验的作液,建议您现现配,当天使; 以下溶剂前显的百分 指该溶剂在您配制终溶液中的体积占;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的式助溶1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (5.78 mM); Clear solution此案可获得 2.5 mg/mL (5.78 mM,饱和度未知) 的澄清溶液。以 1 mL 作液为例,取 100 L 25.0 mg/mL 的澄 DMSO 储备液加到 400
4、L PEG300 中,混合均匀;向上述体系中加50 L Tween-80,混合均匀;然后继续加 450 L 理盐定容 1 mL。2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (5.78 mM); Clear solutionPage 1 of 2 www.MedChemE此案可获得 2.5 mg/mL (5.78 mM,饱和度未知) 的澄清溶液。以 1 mL 作液为例,取 100 L 25.0 mg/mL 的澄 DMSO 储备液加到 900 L 20% 的 SBE-CD 理盐溶液中,混合均匀。3.
5、请依序添加每种溶剂: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (5.78 mM); Clear solution此案可获得 2.5 mg/mL (5.78 mM,饱和度未知) 的澄 溶液,此案不适于实验周 期在半个以上的实验。以 1 mL 作液为例,取 100 L 25.0 mg/mL 的澄 DMSO 储备液加到 900 L 油中,混合均匀。BIOLOGICAL ACTIVITY物活性 Genistin和产品的主要异黄酮。体外研究 Genistin is the major isoflavonoid of soybeans and soy prod
6、ucts. Genistin shows a dose-dependent superoxidescavenging effect and exhibits major effect at 200 M, corresponding in activity to 0.08 U/mg protein superoxidedismutase (SOD). Results demonstrate that Genistin exhibits a significantly (P0.01) and a dose-dependent inhibitoryeffect on the human cancer
7、 cell examined, and at higher concentration (100 M), the cell viability is 59%. Genistin alsoinduces a significant and dose-dependent increase in ROS formation when compare with the untreated control1.体内研究 Myocardial infarct is markedly diminished by pretreatment with Genistin, particularly at the h
8、igh dose. After 1 h ofreperfusion, preconditioning with Genistin at dosages of 20 to 60 mg/kg significantly attenuats the release of lactate dehydrogenase (LDH), creatine kinase (CK) in a dose-dependent manner compare with the I/R group. Results showthat the level of malondialdehyde (MDA) is decreas
9、ed and the activities of superoxide dismutase (SOD) and catalase(CAT) are increased as well as an increased glutathione (GSH) level in a dose-dependent manner by Genistintreatment in I/R. Pretreatment with Genistin (20, 40 and 60 mg/kg) also prevents the expression of P2X7, p-IB, andp-NF-B p65 compa
10、re with the model group2.PROTOCOLCell Assay 1 M14 human melanoma cells are used and grown in RPMI containing 10% fetal calf serum, 100 U/mL penicillin, 100 g/mL streptomycin, and 25 g/mL fungizone. After 24 h of incubation at 37C under a humidified 5% carbon dioxideto allow cell attachment, the cell
11、s are treated with different concentrations (12, 25, 50, and 100 M) of Genistin anddaidzin, and incubated for 72 h under the same conditions1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Sprague-Dawley rats (male, 250 to 300 g) are used to est
12、ablish the I/R injury animal model and used in thisAdministration 2 experiment. Rats are randomly apportioned in equal animals (n=10) to five experimental groups: (1) sham group: ratsare subjected to the entire surgical procedure but without the induction of I/R; (2) model group: I/R injury animalmo
13、del is constructed by left anterior descending coronary artery (LAD) ligation for 30 min, and then the LAD isallowed 1 h reperfusion; and (3) three Genistin-treated groups: different doses (20, 40, and 60 mg/kg body weight,resp.) of Genistin dissolved in 0.5% sodium carboxyl methyl cellulose (CMC-Na
14、) solution are given intragastrically for5 days before operation2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Russo A, et al. Genistin inhibits UV light-induced plasmid DNA damage and cell growth in human melanoma cells. J Nutr Biochem. 2006 Feb;17(2):103-8.Page 2 of 3 www.MedChemE2. Gu M, et al. Cardioprotective Effects of Genistin in Rat Myocardial Ischemia-Reperfusion Injury Studies by Regulation of P2X7/NF-B Pathway. Evid BasedComplement Alternat Med. 2016;2016:5381290.
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 二零二五年度夫妻共同财产分割及居住权协议
- 2025版网络安全技术服务合同范本(含年度维护服务)
- 二零二五年度建筑安装工程施工许可证办理服务合同
- 二零二五年度历史文化保护区修复装修工程合同
- 2025版海洋工程建设项目施工结算与海洋环境保护协议
- 麻醉个案护理汇报课件
- 2025版大摩退出中金项目合作终止协议
- 二零二五版堆场货物装卸与仓储管理协议
- 窦姣离婚协议书及子女抚养权及探视权安排
- 二零二五年度重型吊车转让及运输保险合同
- 2025至2030中国多晶硅行业供给预测与未来趋势前景预判报告
- 代卖材料合同协议书范本
- 潍坊银行笔试题库及答案
- 护理学科研创新试题及答案
- 日本签证个人信息处理同意书
- DB50∕T 632-2015 火灾高危单位消防安全评估规程
- 从患者画像到个性化治疗医疗大数据的作用路径
- 盾构施工安全培训教育全面版
- 流动餐车走街串巷的美食之旅
- 配电网建设知识培训课件
- 井下矿山顶板安全知识培训
评论
0/150
提交评论